HLTH:AU:AU-VanEck Global Healthcare Leaders ETF (AUD)

ETF | Others |

Last Closing

USD 11.09

Change

+0.07 (+0.64)%

Market Cap

USD 0.06B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.90 (+0.95%)

USD 15.34B
VGS:AU Vanguard MSCI International Sh..

-0.41 (-0.33%)

USD 7.71B
IVV:AU iShares Core S&P 500 AUD

-0.41 (-0.77%)

USD 7.58B
IOZ:AU Ishares Core S&P/Asx 200

+0.32 (+1.04%)

USD 5.50B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.37 (-0.67%)

USD 5.47B
STW:AU SPDR® S&P/ASX 200 Fund

+0.70 (+1.01%)

USD 5.11B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

-0.26 (-0.67%)

USD 4.86B
A200:AU BetaShares Australia 200

+1.27 (+0.99%)

USD 4.72B
NDQ:AU Betashares Nasdaq 100

-0.53 (-1.24%)

USD 4.37B
VTS:AU Vanguard US Total Market Share..

-2.61 (-0.67%)

USD 3.95B

ETFs Containing HLTH:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.77% 56% F 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.77% 53% F 66% D+
Trailing 12 Months  
Capital Gain 6.53% 40% F 65% D
Dividend Return 1.06% 11% F 7% C-
Total Return 7.59% 32% F 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.96% 27% F 41% F
Dividend Return -0.71% 20% F 38% F
Total Return 0.25% 5% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 8.09% 76% C+ 95% A
Risk Adjusted Return -8.76% 19% F 34% F
Market Capitalization 0.06B 15% F 51% F

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.